-
1دورية أكاديمية
المؤلفون: Long Depaquit T; Department of Urology, HIA Sainte-Anne, Toulon, France; Department of Urology, North Hospital, AP-HM, Marseille, France. Electronic address: thibaut.long2@gmail.com., Campagna J; Department of Urology, North Hospital, AP-HM, Marseille, France., Bastide C; Department of Urology, North Hospital, AP-HM, Marseille, France., Baboudjian M; Department of Urology, North Hospital, AP-HM, Marseille, France., Corral R; Department of Urology, HIA Sainte-Anne, Toulon, France; Department of Urology, North Hospital, AP-HM, Marseille, France; Department of Urology, Martigues Hospital, Martigues, France., Uleri A; Department of Urology, North Hospital, AP-HM, Marseille, France., Toledano H; Department of Urology, North Hospital, AP-HM, Marseille, France; Department of Urology, Martigues Hospital, Martigues, France.
المصدر: The French journal of urology [Fr J Urol] 2024 Jun; Vol. 34 (5), pp. 102633. Date of Electronic Publication: 2024 Mar 26.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Masson SAS Country of Publication: France NLM ID: 9918752079106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2950-3930 (Electronic) Linking ISSN: 29503930 NLM ISO Abbreviation: Fr J Urol Subsets: MEDLINE
مواضيع طبية MeSH: Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/mortality , Prostatic Neoplasms*/therapy , Salvage Therapy*/methods , Neoplasm Recurrence, Local*/pathology, Humans ; Male ; Aged ; Middle Aged ; Retrospective Studies ; Ultrasound, High-Intensity Focused, Transrectal ; Treatment Outcome ; Disease Progression ; Aged, 80 and over
-
2دورية أكاديمية
المؤلفون: Joy Trybula S; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Nandoliya KR; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Youngblood MW; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Karras CL; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Fernandez LG; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Oyon DE; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Texakalidis P; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Khan OH; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Lesniak MS; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Tate MC; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Rosenow JM; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Hill VB; Department of Radiology, Division of Neuroradiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Hijaz TA; Department of Radiology, Division of Neuroradiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Russell EJ; Department of Radiology, Division of Neuroradiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Sachdev S; Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL, USA., Kalapurakal JA; Department of Radiation Oncology, Northwestern Memorial Hospital, Chicago, IL, USA., Horbinski CM; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Pathology, Northwestern Memorial Hospital, Chicago, IL, USA., Magill ST; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Electronic address: stephen.magill@northwestern.edu., Chandler JP; Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
المصدر: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2024 Jun; Vol. 124, pp. 102-108. Date of Electronic Publication: 2024 Apr 28.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9433352 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2653 (Electronic) Linking ISSN: 09675868 NLM ISO Abbreviation: J Clin Neurosci Subsets: MEDLINE
مواضيع طبية MeSH: Salvage Therapy*/methods , Meningioma*/radiotherapy , Meningioma*/surgery , Radiosurgery*/methods , Meningeal Neoplasms*/radiotherapy , Meningeal Neoplasms*/surgery, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Adult ; Radiotherapy, Adjuvant ; Aged, 80 and over ; Neurosurgical Procedures/methods ; Follow-Up Studies ; Disease Progression
-
3دورية أكاديمية
المؤلفون: Chou MY; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C., Wu WC; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C., Chu PY; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C., Tai SK; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C., Chang PM; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.; Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C., Lee TL; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C., Chen TH; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C., Yang MH; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.; mhyang2@vghtpe.gov.tw.; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.; Cancer and Immunology Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, R.O.C.
المصدر: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 1891-1899.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE
مواضيع طبية MeSH: Salvage Therapy* , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/pathology , Head and Neck Neoplasms*/mortality , Drug Resistance, Neoplasm* , Paclitaxel*/administration & dosage , Paclitaxel*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Neoplasm Recurrence, Local*/drug therapy , Neoplasm Recurrence, Local*/pathology , Ifosfamide*/therapeutic use , Ifosfamide*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Retrospective Studies ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/mortality ; Squamous Cell Carcinoma of Head and Neck/pathology ; Platinum/therapeutic use ; Neoplasm Metastasis ; Aged, 80 and over ; Treatment Outcome
-
4دورية أكاديمية
المؤلفون: Valentini M; Department of Otolaryngology Head and Neck Surgery, Department of Biotechnology and Life Sciences, ASST Lariana, Ospedale Sant'Anna, University of Insubria, 22042, Como, San Fermo Della Battaglia, Italy. mvlntn92@gmail.com.; Head and Neck Surgery and Forensic Dissection Research Center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, 21100, Varese, Italy. mvlntn92@gmail.com., Lambertoni A; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy., Sileo G; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy., Arosio AD; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy., Dalfino G; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy., Pedretti F; Department of Otolaryngology, University of Pavia, 27100, Pavia, Italy., Karligkiotis A; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy., Bignami M; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy.; Head and Neck Surgery and Forensic Dissection Research Center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, 21100, Varese, Italy., Battaglia P; Department of Otolaryngology Head and Neck Surgery, Department of Biotechnology and Life Sciences, ASST Lariana, Ospedale Sant'Anna, University of Insubria, 22042, Como, San Fermo Della Battaglia, Italy.; Head and Neck Surgery and Forensic Dissection Research Center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, 21100, Varese, Italy., Castelnuovo P; Department of Otorhinolaryngology Head and Neck Surgery, Ospedale di Circolo e Fondazione Macchi, Department of Biotechnology and Life Sciences, ASST Sette Laghi, University of Insubria, 21100, Varese, Italy.; Head and Neck Surgery and Forensic Dissection Research Center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, 21100, Varese, Italy., Turri-Zanoni M; Department of Otolaryngology Head and Neck Surgery, Department of Biotechnology and Life Sciences, ASST Lariana, Ospedale Sant'Anna, University of Insubria, 22042, Como, San Fermo Della Battaglia, Italy.; Head and Neck Surgery and Forensic Dissection Research Center (HNS&FDRc), Department of Biotechnology and Life Sciences, University of Insubria, 21100, Varese, Italy.
المصدر: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2024 Jul; Vol. 281 (7), pp. 3601-3613. Date of Electronic Publication: 2024 Mar 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9002937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-4726 (Electronic) Linking ISSN: 09374477 NLM ISO Abbreviation: Eur Arch Otorhinolaryngol Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasm Recurrence, Local*/surgery , Nasopharyngeal Carcinoma*/surgery , Nasopharyngeal Carcinoma*/mortality , Nasopharyngeal Carcinoma*/pathology , Nasopharyngeal Neoplasms*/surgery , Nasopharyngeal Neoplasms*/pathology , Endoscopy*/methods , Pharyngectomy*/methods , Salvage Therapy*/methods, Humans ; Male ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Aged ; Survival Rate ; Disease-Free Survival
-
5دورية أكاديمية
المؤلفون: Seto Y; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan., Ishitobi M; Department of Breast Surgery, Mie University School of Medicine, Tsu, Japan. pu-tobi-100306@docomo.ne.jp., Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan., Oshiro C; Department of Breast Surgery, Kaizuka City Hospital, Kaizuka, Japan., Inoue H; Department of Thoracic, Endocrine Surgery and Oncology, Tokushima University Graduate School of Medical Sciences, Tokushima, Japan., Shima H; Department of Surgery, Surgical Oncology and Science, Sapporo Medical University, Osaka, Japan., Kuba S; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Watanabe N; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan., Iwatani T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan., Nakayama T; Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan.
المصدر: Annals of surgical oncology [Ann Surg Oncol] 2024 Jul; Vol. 31 (7), pp. 4512-4517. Date of Electronic Publication: 2024 Apr 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasm Recurrence, Local*/surgery , Neoplasm Recurrence, Local*/pathology , Patient Preference* , Breast Neoplasms*/surgery , Breast Neoplasms*/pathology , Salvage Therapy* , Mastectomy, Segmental*/methods, Humans ; Female ; Middle Aged ; Aged ; Mastectomy ; Adult ; Follow-Up Studies ; Prognosis
-
6دورية أكاديمية
المؤلفون: Williamson A; Department of Head and Neck Surgery, The Royal Marsden Hospital, International Centre for Recurrent Head and Neck Cancer (IReC), London, United Kingdom.; Institute for Cancer Research, London, United Kingdom., Shah F; Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Benaran I; Department of Otolaryngology, Head and Neck Surgery, Monklands University Hospital, Glasgow, United Kingdom., Paleri V; Department of Head and Neck Surgery, The Royal Marsden Hospital, International Centre for Recurrent Head and Neck Cancer (IReC), London, United Kingdom.; Institute for Cancer Research, London, United Kingdom.
المصدر: The Laryngoscope [Laryngoscope] 2024 Jul; Vol. 134 (7), pp. 2991-3002. Date of Electronic Publication: 2024 Jan 18.
نوع المنشور: Journal Article; Meta-Analysis; Review
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8607378 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-4995 (Electronic) Linking ISSN: 0023852X NLM ISO Abbreviation: Laryngoscope Subsets: MEDLINE
مواضيع طبية MeSH: Laryngectomy*/adverse effects , Laryngectomy*/methods , Salvage Therapy*/methods , Surgical Flaps*/transplantation , Network Meta-Analysis* , Postoperative Complications*/epidemiology , Postoperative Complications*/prevention & control , Postoperative Complications*/etiology , Cutaneous Fistula*/etiology , Cutaneous Fistula*/prevention & control , Cutaneous Fistula*/surgery , Cutaneous Fistula*/epidemiology, Humans ; Pharyngeal Diseases/etiology ; Pharyngeal Diseases/prevention & control ; Pharyngeal Diseases/surgery ; Laryngeal Neoplasms/surgery ; Incidence ; Fistula/etiology ; Fistula/prevention & control ; Fistula/surgery ; Fistula/epidemiology
-
7Editorial & Opinion
المؤلفون: Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, USA. Electronic address: Daniel.spratt@uhhospitals.org.
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 585-587. Date of Electronic Publication: 2024 May 09.
نوع المنشور: Editorial
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Salvage Therapy*/methods, Humans ; Radiotherapy, Adjuvant/methods ; Radiotherapy, Adjuvant/standards ; Neoplasms/radiotherapy
-
8دورية أكاديمية
المؤلفون: Thakker PU; Department of Urology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Sandberg M; Department of Urology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Hemal AK; Department of Urology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Rodriguez AR; Department of Urology, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
المصدر: International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2024 Jul-Aug; Vol. 50 (4), pp. 398-414.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: Brazilian Society of Urology Country of Publication: Brazil NLM ID: 101158091 Publication Model: Print Cited Medium: Internet ISSN: 1677-6119 (Electronic) Linking ISSN: 16775538 NLM ISO Abbreviation: Int Braz J Urol Subsets: MEDLINE
-
9دورية أكاديمية
المؤلفون: Parker CC; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, Sutton, UK. Electronic address: chris.parker@rmh.nhs.uk., Petersen PM; Department of Oncology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Clarke NW; Department of Urology, The Christie NHS Foundation Trust, Manchester; Manchester Cancer Research Centre, The University of Manchester, Manchester; Department of Urology, Salford Royal NHS Foundation Trust, Manchester, UK, Department of Urology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK., Catton C; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Cross WR; Department of Urology, St James's University Hospital, Leeds., Kynaston H; Division of Cancer and Genetics, Cardiff University, Cardiff, UK., Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, Canada., Persad RA; Department of Urology, Bristol Urological Institute, Bristol, UK., Saad F; Department of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, Canada., Bower L; Guy's and St Thomas' NHS Foundation Trust, London; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK., Durkan GC; Department of Urology, University Hospital Galway, Galway, Ireland., Logue J; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester., Maniatis C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Noor D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Payne H; The Prostate Centre, London., Anderson J; St James's Institute of Oncology, Leeds., Bahl AK; Bristol Haematology and Oncology Centre, University Hospitals Bristol & Weston NHS Trust, Bristol., Bashir F; Queen's Centre for Oncology, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Cottingham, UK., Bottomley DM; St James's Institute of Oncology, Leeds., Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Capaldi L; Worcester Oncology Centre, Worcestershire Acute NHS Hospitals Trust, Worcester., Chung C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Cooke PW; Department of Urology, The Royal Wolverhampton NHS Trust, Wolverhampton., Donohue JF; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone., Eddy B; East Kent University Hospitals Foundation Trust, Kent., Heath CM; Department of Clinical Oncology, University Hospital Southampton NHS Foundation Trust, Southampton., Henderson A; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone., Henry A; Leeds Institute of Medical Research, University of Leeds, Leeds., Jaganathan R; Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Jakobsen H; Department of Urology, Herlev University Hospital, Herlev, Denmark., James ND; Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, UK., Joseph J; Leeds Teaching Hospitals; York and Scarborough Teaching Hospitals, York., Lees K; Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust, Maidstone., Lester J; South West Wales Cancer Centre, Singleton Hospital, Swansea, UK., Lindberg H; Department of Oncology, Herlev University Hospital, Herlev, Denmark., Makar A; Department of Urology, Worcestershire Acute Hospitals Trust, Worcester., Morris SL; Guy's and St Thomas' NHS Foundation Trust, London., Oommen N; Wrexham Maelor Hospital, Wrexham., Ostler P; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London., Owen L; Bradford Royal Infirmary, Bradford; Leeds Cancer Centre, Leeds., Patel P; Department of Urology, University College London Hospitals, London., Pope A; Department of Urology, Hillingdon Hospitals NHS Foundation Trust, Hillingdon, London., Popert R; Guy's and St Thomas' NHS Foundation Trust, London., Raman R; Kent Oncology Centre, Kent & Canterbury Hospital, Canterbury., Ramani V; Department of Urology, The Christie NHS Foundation Trust, Manchester., Røder A; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen., Sayers I; Deanesly Centre, New Cross Hospital, Wolverhampton., Simms M; Department of Urology, Hull University Hospitals NHS Trust, Hull., Srinivasan V; Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl., Sundaram S; Department of Urology, Mid Yorkshire Teaching Hospital, Wakefield., Tarver KL; Department of Oncology, Queen's Hospital, Romford., Tran A; Department of Oncology, The Christie Hospital NHS FT, Wilmslow Road, Manchester., Wells P; Barts Cancer Centre, St Bartholomews Hospital, London., Wilson J; Royal Gwent Hospital, Newport., Zarkar AM; Department of Oncology, University Hospitals Birmingham, Birmingham, UK., Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London. Electronic address: mrcctu.radicals@ucl.ac.uk.
مؤلفون مشاركون: RADICALS investigators
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jul; Vol. 35 (7), pp. 656-666. Date of Electronic Publication: 2024 Apr 05.
نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study
بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Prostatectomy*/methods , Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/surgery , Prostatic Neoplasms*/pathology , Salvage Therapy*/methods, Humans ; Male ; Aged ; Middle Aged ; Radiotherapy, Adjuvant/adverse effects ; Radiotherapy, Adjuvant/methods ; Prostate-Specific Antigen/blood ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Grading ; Time Factors
-
10دورية أكاديمية
المؤلفون: Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; UCLA-Caltech Medical Scientist Training Program, David Geffen School of Medicine, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Booker KM; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Grogan TR; Department of Medicine Statistics Core (DOMStat), David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Elashoff D; Department of Medicine Statistics Core (DOMStat), David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Lam EC; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Clark KJ; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Fendler WP; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK) - University Hospital Essen, Essen, Germany., Hope TA; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA., Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA; Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: jcalais@mednet.ucla.edu.
المصدر: European urology [Eur Urol] 2024 Jul; Vol. 86 (1), pp. 52-60. Date of Electronic Publication: 2024 Jan 29.
نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
مواضيع طبية MeSH: Prostatic Neoplasms*/radiotherapy , Prostatic Neoplasms*/diagnostic imaging , Prostatic Neoplasms*/surgery , Prostatic Neoplasms*/pathology , Positron Emission Tomography Computed Tomography*/methods , Salvage Therapy*, Humans ; Male ; Prospective Studies ; Aged ; Middle Aged ; Glutamate Carboxypeptidase II/metabolism ; Antigens, Surface/metabolism ; Neoplasm Recurrence, Local/diagnostic imaging ; Prostatectomy/methods